Heterogeneous photocatalytic removal of toluene from air on building materials enriched with TiO2

This paper reports the potential of heterogeneous photocatalysis as an advanced oxidation technology for removal of toluene from air using TiO₂ as a photocatalyst in building materials. First, the photocatalytic activity of two types of TiO₂ containing building materials, i.e. roofing tiles and corrugated sheets, has been investigated at ambient conditions (T=25.0 °C; relative humidity RH=47%; toluene inlet concentration [TOL]_in=17–35 ppbv). Toluene removal efficiencies up to 63% were observed at a gas residence time (τ) of 17 s. Second, the effect of RH (1–77%), [TOL]_in (23–465 ppmv) and τ (17–115 s) on toluene removal has been systematically investigated using TiO₂ containing roofing tiles as photocatalytic building materials. Results revealed lower toluene removal efficiencies at higher RH and [TOL]_in, whereas a positive effect was observed with increased τ. Under optimal conditions, toluene removal efficiencies up to 78±2% and elimination rates higher than 100 mg h⁻¹ m⁻² roofing tile were obtained. A decline in photocatalytic activity by a factor of 2 was observed after operation at gas residence times shorter than 69 s and [TOL]_in higher than 76 ppmv. Washing the building materials with deionized water, simulating rainfall, could partially (i.e. by a factor 1.3) regenerate the catalyst activity.     

Transparent exopolymer particle removal in different drinking water production centers

Transparent exopolymer particles (TEP) have recently gained interest in relation to membrane fouling. These sticky, gel-like particles consist of acidic polysaccharides excreted by bacteria and algae. The concentrations, expressed as xanthan gum equivalents L⁻¹ (μg X_eq L⁻¹), usually reach hundred up to thousands μg X_eq L⁻¹ in natural waters. However, very few research was performed on the occurrence and fate of TEP in drinking water, this far. This study examined three different drinking water production centers, taking in effluent of a sewage treatment plant (STP), surface water and groundwater, respectively. Each treatment step was evaluated on TEP removal and on 13 other chemical and biological parameters. An assessment on TEP removal efficiency of a diverse range of water treatment methods and on correlations between TEP and other parameters was performed. Significant correlations between particulate TEP (>0.4 μm) and viable cell concentrations were found, as well as between colloidal TEP (0.05-0.4 μm) and total COD, TOC, total cell or viable cell concentrations. TEP concentrations were very dependent on the raw water source; no TEP was detected in groundwater but the STP effluent contained 1572 μg X_eq L⁻¹ and the surface water 699 μg X_eq L⁻¹. Over 94% of total TEP in both plants was colloidal TEP, a fraction neglected in nearly every other TEP study. The combination of coagulation and sand filtration was effective to decrease the TEP levels by 67%, while the combination of ultrafiltration and reverse osmosis provided a total TEP removal. Finally, in none of the installations TEP reached the final drinking water distribution system at significant concentrations. Overall, this study described the presence and removal of TEP in drinking water systems.     

Quantitation of Ink Transferred During Pharmaceutical Printing Operations Using Inductively Coupled Plasma Atomic Emission Spectroscopy

The identification of solid dosage forms is often achieved through printing with a non-toxic ink. Due to product purity requirements, a method to quantify the amount of ink applied to tablets and capsules is of interest to the pharmaceutical industry.

The following presentation investigated the use of inductively coupled plasma atomic emission spectroscopy (ICP-AES) as a direct method of quantifying the amount of ink on a tablet. Because the ink used contained an iron oxide pigment of known composition, quantitation of the iron content could be used to measure the amount of ink transferred to the tablet.

The quantitative results obtained using ICP-AES were in agreement with calculated values for the volume of ink in the gravure roll. Tablets exposed to “double printing” were easily detected by the ICP-AES method.     

Inhibition of angiotensin I-converting enzyme by wheat gliadin hydrolysates

A tryptic gliadin hydrolysate was fractionated into peptide fractions, which were assigned to either the central domain (CD) or terminal domains (TD) of gliadins. The domains were expected to contain amino acid (AA) sequences which, when released from the parent protein, inhibit the angiotensin I-converting enzyme (ACE), which plays a key role in regulating blood pressure. A proline (Pro) poor TD related fraction, containing the smallest peptides, showed the highest ACE inhibitory activity (IC₅₀ = 0.33 mg/ml). Additional peptidases were selected based on their in silico predicted ability to release ACE inhibitory peptides. Further hydrolysis of the tryptic hydrolysate fractions with thermolysin, Clarex, Alcalase and Esperase increased ACE inhibitory activities. Immobilised Ni²⁺-ion affinity chromatography (IMAC) purification of a TD related peptide fraction obtained by sequential hydrolysis with trypsin and thermolysin yielded a fraction with an IC₅₀ value of 0.02 mg/ml. This IMAC fraction was enriched in histidine and hydrophobic AA (Pro, Val, Ile, Leu and Phe).     

Intercomparison exercise of high pressure gas flow test facilities within GERG

Ten of the main European gas Companies decided to carry out the second intercomparison exercise of high pressure test facilities within GERG (Groupe Européen de Recherches Gazières). The survey has compared the performances of 8 high pressure gas flow laboratories in the period autumn 1998–autumn 1999.

The aim was to check to what extent results obtained at the various laboratories are comparable and to reveal possible ways of improving the performances. Tests have been carried out using three transfer standard packages of three different diameters. The considered performance parameters have been: (1) agreement of results between laboratories, (2) short term stability and (3) day to day reproducibility of the reference flow.

The following main conclusions have been drawn:

• The majority of the laboratories involved in the intercomparison produced very accurate results. Despite the involvement of five independent traceability chains, 92.5% of the test results are within a band of ±0.25%.

• For most facilities the short term fluctuations are of the order of ±0.1%. Individual facilities may perform even better.

• This exercise allowed us to confirm the good results of the previous campaign and to identify some items to improve future intercomparisons.

Zwitterionic‐Coated “Stealth” Nanoparticles for Biomedical Applications: Recent Advances in Countering Biomolecular Corona Formation and Uptake by the Mononuclear Phagocyte System

Nanoparticles represent highly promising platforms for the development of imaging and therapeutic agents, including those that can either be detected via more than one imaging technique (multi‐modal imaging agents) or used for both diagnosis and therapy (theranostics). A major obstacle to their medical application and translation to the clinic, however, is the fact that many accumulate in the liver and spleen as a result of opsonization and scavenging by the mononuclear phagocyte system. This focused review summarizes recent efforts to develop zwitterionic‐coatings to counter this issue and render nanoparticles more biocompatible. Such coatings have been found to greatly reduce the rate and/or extent of non‐specific adsorption of proteins and lipids to the nanoparticle surface, thereby inhibiting production of the “biomolecular corona” that is proposed to be a universal feature of nanoparticles within a biological environment. Additionally, in vivo studies have demonstrated that larger‐sized nanoparticles with a zwitterionic coating have extended circulatory lifetimes, while those with hydrodynamic diameters of ≤5 nm exhibit small‐molecule‐like pharmacokinetics, remaining sufficiently small to pass through the fenestrae and slit pores during glomerular filtration within the kidneys, and enabling efficient excretion via the urine. The larger particles represent ideal candidates for use as blood pool imaging agents, whilst the small ones provide a highly promising platform for the future development of theranostics with reduced side effect profiles and superior dose delivery and image contrast capabilities.